Please provide your email address to receive an email when new articles are posted on . SEATTLE — A laboratory study showed significant variation in accuracy and residual volume among syringes ...
Baseline plasma matrix metalloproteinase 9 (MMP9) to predict overall survival (OS) benefit from bevacizumab (BEV) in newly diagnosed glioblastoma (GBM): Retrospective analysis of AVAglio. This is an ...
Long term outcome in patients with cisplatin-refractory or multiply relapsed germ cell tumors following treatment with gemcitabine and oxaliplatin ± paclitaxel. Background: Residual tumor resection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results